New strategy aims to stop liver cancer from coming back
NCT ID NCT07461675
Summary
This study is testing if giving an immunotherapy drug called atezolizumab before surgery to remove liver cancer can help prevent the cancer from returning. Researchers want to see if boosting the patient's immune system before the operation is more effective than surgery alone. The trial will involve 30 patients with early-stage liver cancer who are scheduled for surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Geneva University Hospitals
Geneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.